publicações selecionadas
-
artigo académico
- Epigenetically-regulated miR-30a/c-5p directly target TWF1 and hamper ccRCC cell aggressiveness. Translational Research. 2022
- Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastoma. Molecular Oncology. 2022
- Chronic Stress Does Not Influence the Survival of Mouse Models of Glioblastoma. Frontiers in Oncology. 2022
- Fucoidan/chitosan nanoparticles functionalized with anti-ErbB-2 target breast cancer cells and impair tumor growth in vivo. International Journal of Applied Pharmaceutics. 2021
- A novel molecular link between HOXA9 and WNT6 in glioblastoma identifies a subgroup of patients with particular poor prognosis. Molecular Oncology. 2020
-
artigo de revista
- The Role of Network Science in Glioblastoma. Cancers. 2021
- Intracellular Autofluorescence as a New Biomarker for Cancer Stem Cells in Glioblastoma. Cancers. 2021
- WNT6 is a novel oncogenic prognostic biomarker in human glioblastoma. Theranostics. 2018
-
documento
- CDH3/P-cadherin is a novel oncogenic biomarker with prognostic value in glioblastoma 2020
- Deciphering WNT6 up and down roads in glioblastoma: mechanistic, functional, and clinical insight 2020
- Functional and prognostic relevance of CDH3/P-cadherin in glioblastoma 2019
- WNT6 is a novel oncogenic prognostic biomarker in human glioblastoma 2019
- Deciphering key roles of WNT6 in glioblastoma: mechanistic, functional, and clinical insights 2019
- CDH3/P-cadherin expression is associated with aggressiveness of human glioblastoma 2018
- CDH3/P-cadherin as a novel biomarker in glioblastoma: functional and prognostic insights 2018
- WNT6 is a novel oncogenic prognostic biomarker in human glioblastoma 2018
- CDH3/P-cadherin as a putative HOXA9 target in gliomas: functional and clinical relevance 2017
- Updating TCGA glioma classification through integration of molecular profiling data following the 2016 and 2021 WHO guidelines
-
teses